Eli Lilly and Company (LLY)
Official siteHEALTHCARE • DRUG MANUFACTURERS - GENERAL • NYSE
Market Cap: $1.29T
Last updated: Nov 17, 2026 at 11:06 AM ET
Eli Lilly and Company (LLY) Competitors
The companies most similar to Eli Lilly and Company are Johnson & Johnson (JNJ), AbbVie (ABBV) and Merck & Company (MRK). Eli Lilly and Company trades at 44.9x earnings, against a median of 19.9x for the 9 of these companies with a P/E. By market cap, Eli Lilly and Company is the largest of the 13 companies on this page, at $1.29T.
Peer Comparison
LLY's ROIC of 30.7% is above the peer median of 13.5%, and its revenue growth of 38.6% is above the median of 6.3%. Its dividend yield is below the peer median of 2.67%.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Eli Lilly and Company (LLY) | $1.29T | 44.9x | 14.8x | 31.9% | 30.7% | 38.6% | 0.48% |
| Johnson & Johnson (JNJ) | $687.89B | 26.6x | 6.9x | 16.2% | 12.8% | 5.9% | 1.90% |
| AbbVie Inc (ABBV) | $521.50B | 23.0x | 7.9x | 15.7% | 16.4% | 10.3% | 2.35% |
| Merck & Company Inc (MRK) | $364.26B | 46.3x | 5.3x | 3.6% | 3.1% | 4.7% | 2.35% |
| Pfizer Inc (PFE) | $164.67B | 9.5x | 2.6x | 6.3% | 2.7% | -0.4% | 5.96% |
| Bristol-Myers Squibb Company (BMY) | $129.66B | 10.1x | 2.6x | 18.5% | 13.9% | 6.9% | 4.00% |
| Gilead Sciences Inc (GILD) | $208.48B | N/A | 6.7x | -12.5% | -3.9% | 6.8% | 1.96% |
| AstraZeneca PLC (AZN) | $286.07B | 22.5x | 4.6x | 17.7% | 14.9% | 6.7% | 1.16% |
| Sanofi ADR (SNY) | $116.15B | N/A | 2.0x | 8.2% | 7.6% | 15.7% | 5.01% |
| Novartis AG ADR (NVS) | $303.12B | 18.7x | 5.4x | 17.5% | 13.5% | 4.7% | 2.98% |
| Novo Nordisk A/S (NVO) | $183.52B | N/A | 3.6x | 33.9% | 34.1% | 5.6% | 4.32% |
| GSK plc (GSK) | $101.13B | 10.5x | 2.3x | 13.0% | N/A | 4.0% | 3.58% |
| Amgen Inc (AMGN) | $251.89B | 19.9x | 6.4x | 24.1% | 17.0% | 8.5% | 2.18% |
| Peer median | $230.18B | 19.9x | 5.0x | 15.9% | 13.5% | 6.3% | 2.67% |
Similar Companies
These are the 12 companies most similar to Eli Lilly and Company, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Drug Manufacturers - General.
| Company | About | Peers |
|---|---|---|
| Johnson & Johnson (JNJ) | Johnson & Johnson (J&J) is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged goods. | JNJ competitors |
| AbbVie Inc (ABBV) | AbbVie is an American publicly traded biopharmaceutical company founded in 2013. It originated as a spin-off of Abbott Laboratories. | ABBV competitors |
| Merck & Company Inc (MRK) | Merck & Co. is an American multinational pharmaceutical company headquartered in Kenilworth, New Jersey. | MRK competitors |
| Pfizer Inc (PFE) | Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered on 42nd Street in Manhattan, New York City. | PFE competitors |
| Bristol-Myers Squibb Company (BMY) | Bristol Myers Squibb (BMS) is an American multinational pharmaceutical company, headquartered in New York City. | BMY competitors |
| Gilead Sciences Inc (GILD) | Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California... | GILD competitors |
| AstraZeneca PLC (AZN) | AstraZeneca PLC discovers, develops, manufactures and markets prescription drugs in the areas of oncology, cardiovascular, renal and metabolism, respiratory... | AZN competitors |
| Sanofi ADR (SNY) | Sanofi, a healthcare company, is engaged in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe... | SNY competitors |
| Novartis AG ADR (NVS) | Novartis AG researches, develops, manufactures and markets medical devices worldwide. The company is headquartered in Basel, Switzerland. | NVS competitors |
| Novo Nordisk A/S (NVO) | Novo Nordisk A / S, a healthcare company, is dedicated to the research, development, manufacture and marketing of pharmaceutical products globally. | NVO competitors |
| GSK plc (GSK) | GlaxoSmithKline plc is dedicated to the creation, discovery, development, manufacture and marketing of pharmaceuticals, vaccines... | GSK competitors |
| Amgen Inc (AMGN) | Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. | AMGN competitors |
Frequently Asked Questions About LLY
Who are Eli Lilly and Company's main competitors?
The companies most similar to Eli Lilly and Company include Johnson & Johnson (JNJ), AbbVie (ABBV), Merck & Company (MRK), Pfizer (PFE) and Bristol-Myers Squibb Company (BMY), listed from the closest match.
Who is Eli Lilly and Company's biggest competitor?
Johnson & Johnson (JNJ) is both the largest of the similar companies at $687.89B and the closest match by business profile, size, sector and industry.
How does LLY stock compare with its competitors?
LLY's P/E is 44.9x against a peer median of 19.9x; its P/S is 14.8x against a peer median of 5.0x; its net margin is 31.9% against a peer median of 15.9%.
Which of Eli Lilly and Company's competitors pays a higher dividend?
Eli Lilly and Company has a forward dividend yield of 0.48%. Pfizer (PFE), Sanofi ADR (SNY), Novo Nordisk A/S (NVO), Bristol-Myers Squibb Company (BMY), GSK (GSK), Novartis AG ADR (NVS), Merck & Company (MRK), AbbVie (ABBV), Amgen (AMGN), Gilead Sciences (GILD), Johnson & Johnson (JNJ) and AstraZeneca (AZN) have higher forward dividend yields; Pfizer (PFE) has the highest at 5.96%.
Is Eli Lilly and Company bigger than its competitors?
Yes. Eli Lilly and Company is the largest by market cap among the 13 companies on this page, at $1.29T.
LLY pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts